Michael McDermott - 27 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role: Executive Vice President
Signature: /s/ Shanice A. Reid, by power of atty, for Michael McDermott
Issuer symbol: PFE
Transactions as of: 27 Feb 2025
Net transactions value: +$305,337
Form type: 4
Filing time: 03 Mar 2025, 17:37:40 UTC
Previous filing: 28 Feb 2025
Next filing: 06 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Options Exercise	$1,515,999	+48,419	+65%	$31.31	122,413	27 Feb 2025	Direct	F1
transaction	PFE	Common Stock	Tax liability	$28,919	-1,108	-0.91%	$26.10	121,305	27 Feb 2025	Direct	F2
transaction	PFE	Common Stock	Tax liability	$1,181,743	-45,347	-37%	$26.06	75,958	27 Feb 2025	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Options Exercise	$0	-48,419	-100%	$0.000000	0	27 Feb 2025	Common Stock	48,419	$31.31	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2	The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3	The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4	Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.